Human bone marrow contains a population of non-hematopoietic stromal stem/progenitor cells (BMSCs), which play a central role for bone marrow stroma and the hematopoietic microenvironment. However, the precise characteristics and potential stem cell properties of defined BMSC populations have not yet been thoroughly investigated. Using standard adherent colony-forming unit fibroblast (CFU-F) assays, we have previously shown that BMSCs were highly enriched in the nonhematopoietic CD271 pos /CD140a low/neg fraction of normal adult human bone marrow. In this study, we demonstrate that prospectively isolated CD271 pos / CD140a low/neg BMSCs expressed high levels of hematopoiesis supporting genes and signature mesenchymal and multipotency genes on a single cell basis. Furthermore, CD271 pos /CD140a low/neg BMSCs gave rise to nonadherent sphere colonies (mesenspheres) with typical surface marker profile and trilineage in vitro differentiation potential. Importantly, serial transplantations of CD271 pos /CD140a low/neg BMSC-derived mesenspheres (single cell and bulk) into immunodeficient NOD scid gamma (NSG) mice showed increased mesensphere numbers and full differentiation potential after both primary and secondary transplantations. In contrast, BMSC self-renewal potential decreased under standard adherent culture conditions. These data therefore indicate that CD271 pos /CD140a low/neg BMSCs represent a population of primary stem cells with MSC phenotype and sphereforming capacity that fulfill stringent functional stem cell criteria in vivo in a serial transplantation setting.
Introduction

H
uman bone marrow contains a population of nonhematopoietic stromal stem/progenitor cells (BMSCs), which are important components of the hematopoietic stem cell niche, give rise to the hematopoietic stroma upon transplantation, and possess in vivo multilineage differentiation capacities toward skeletal lineages [1] [2] [3] . Despite their key role in bone marrow physiology, little is known about BMSC stem cell characteristics, which is mainly due to the fact that primary BMSCs have thus far been elusive for a precise phenotypical definition. However, recent progress has led to the identification of suitable markers/marker combinations to effectively enrich BMSCs [1, 2, [4] [5] [6] , and furthermore, recently-developed non-adherent mesensphere cultures allowed to assay and amplify potent hematopoiesis-supporting BMSCs while preserving their undifferentiated phenotype [7] .
Using these tools, the current study therefore aimed to investigate key phenotypical and, importantly, functional stem cell properties of prospectively isolated human BMSCs. Our results clearly demonstrate for the first time that non-hematopoietic CD271 pos /CD140a low/neg cells are stromal stem cells with in vivo self-renewal and differentiation potential in a serial transplantation setting.
Materials and Methods
Bone marrow mononuclear cells
In total, bone marrow samples (60 mL) were aspirated from the iliac crest bone of consenting healthy adult donors (n = 41, median age 25 years, and range [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . The study was approved by the local ethics committee. Bone marrow mononuclear cells (BM-MNCs) were isolated by density gradient centrifugation (Ficoll-Paque Premium; GE Healthcare Life Sciences) following incubation with RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (StemCell Technologies) for lineage depletion (CD3, CD14, CD19, CD38, CD66b, and glycophorin A). 
Fluorescence-activated cell sorting
Non-adherent mesensphere cultures
Sorted BM-MNCs were plated at low density (<1,000 cells/cm 2 ) in ultralow adherence plates (Corning) in sphere growth medium as described before [8] . The medium composition is described in detail in the Supplementary Materials and Methods. To prevent cell aggregation, cultures were left untouched for 1 week. Thereafter, half-medium changes were performed twice weekly. Spheres were passaged following enzymatic digestion with 0.25% type I collagenase (StemCell Technologies) for 30 min at 37°C, followed by washing with PBS, and replating at clonal density.
Generation of adherent marrow stromal cells and colony-forming unit fibroblast assays
Sorted BM-MNCs were cultured in standard MSC culture medium [StemMACS MSC Expansion Medium (Miltenyi Biotec, Bergisch Gladbach) plus 1% antibiotic-antimycotic solution (Sigma)]. Medium was changed weekly and passaged as described [2] . Colony-forming unit fibroblast (CFU-F) assays were performed as before [2] and as described in the Supplementary Materials and Methods.
In vitro differentiation assays
Stromal cells derived from adherent and sphere cultures were differentiated toward the adipogenic, osteogenic, and chondrogenic lineages as described [2] . Briefly, for adipogenic differentiation, cells were cultured for 14 days in AdipoDiff medium (Miltenyi Biotec) and stained with Oil red O (Sigma) following fixation. For osteogenic differentiation, cells were cultured in osteogenesis induction medium (see Supplementary Materials and Methods) for 21 days and calcium depositions were visualized by alizarin red staining (Sigma). Chondrogenic differentiation was induced by culturing cell pellets for 28 days in chondrogenesis-induction medium (see Supplementary Materials and Methods). Cryosections of fixed pellets were stained with goat anti-human aggrecan, and nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI; Life Technologies). Sections were analyzed with an Axiovert 200 M fluorescence microscope equipped with an AxioCam HRm camera (both from Carl Zeiss). low/neg cells were expanded under nonadherent and adherent conditions. Spheres and colonies, respectively, were generated both from bulk sorted cells (seeded at clonal densities) and from single sorted cells. After expansion, cells were harvested and loaded overnight on hydroxyapatite/tricalcium phosphate ceramic powder (HA/TCP; Triosite, Zimmer) and then implanted s.c. into 8-week-old NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice.
In vivo transplantation
To evaluate in vivo self-renewal, implants were removed after 8 weeks, digested in 0.25% type I collagenase (STEMCELL Technologies) for 2 h at 37°C, and the harvested cells were stained with anti-mouse CD45 and anti-human CD90 and CD105 antibodies for FACS sorting. To assess the in vivo differentiation capacities, implants were removed after 8 weeks after primary and secondary sections were either stained with hematoxylin/eosin and analyzed as described [9] or prepared for immunohistochemistry as described below. The animal procedures were approved by the local ethics committee on animal experimentation.
Immunohistochemistry
Paraffin-embedded implanted samples were cut into 5 mm thick sections. Sections were deparaffinized and rehydrated following standard protocols [6] . Following antigen retrieval and blocking, sections were stained with primary antibodies (antivimentin, anti-mitochondria, and anti-CD45) and secondary antibodies followed by signal visualization (EnVision labeled polymer HRP; Dako) and microscopic examination using an low/neg BMSCs. 2 · 10 6 events were acquired and plotted for CD271 versus the marker listed on the top after FSC/SSC gating, doublet, and dead cell exclusion (the gating strategy is illustrated in Supplementary Fig. S1A Supplementary Table S1 ) was carried out using the TATAA PreAmp GrandMaster Mix Kit (TATAA Biocenter) and the final product underwent exonuclease treatment (Exonuclease I Kit; New England Biolabs). The samples were mixed with EvaGreen Supermix-low ROX (BioRad) and DNA binding dye and loading reagent (both from Fluidigm), loaded onto the 48.48 Dynamic Array IFC chip, and run on the BioMarkÔ (Fluidigm) system. Data analysis was performed using the BioMark Real-Time PCR Analysis and Singular Analysis Toolset software (Fluidigm). The grouping of the genes as presented in the violin plot analysis was based on published information on gene functions.
Statistical analysis
Data are expressed as mean -standard deviation (mean -SD). Student's t-test and ANOVA were used for statistical analysis.
Results and Discussion
Phenotypical and sphere-forming properties of primary CD271 pos /CD140a low/neg BMSCs
In the last years, considerable progress has been made in the identification of human primary BMSC markers [3, 5] low/neg cells) represented a (close to) pure population of stromal progenitor cells [6] .
As reported, freshly-sorted CD271 pos /CD140a low/neg cells showed typical morphological BMSC features (Fig. 1A) [2, 10] and expressed a typical ''mesenchymal'' stromal cell (MSC) surface marker profile (Fig. 1B) [5, 6, 11] . Expression of CD56, which was reported to identify bone-lining BMSCs [5] , was limited to a small fraction of the cells (Fig. 1B) . Thus, CD56 might be a possible positive marker for endosteal niche BMSCs, complementary to the negative expression of CD146 that we previously reported for this cell population [2] . Expression of integrin a6 (CD49f) on cultured MSC has been implicated in enhancing stem cell properties [12] . Interestingly, CD49f was clearly expressed in about one third of the CD271 pos /CD140a low/neg cells (Fig. 1B) , which might indicate a possible role of CD49f in maintaining stemness of primary BMSCs. Certainly, this is an interesting point that will be addressed in future experiments.
Gene expression profiling of prospectively enriched BMSC has been reported for bulk sorted cells [6, 13, 14] , which has obvious limitations when aiming to characterize highly-purified BMSCs. We therefore investigated the expression of a panel of selected BMSC-relevant genes in single-sorted CD271 pos / CD140a low/neg cells (Fig. 1C, D and Supplementary Table S1 ). CD271 pos /CD140a low/neg cells showed a high and homogeneous expression of CXCL12 and ANGPT (Fig. 1D, group I) , the majority of common MSC-related genes (group II), most of the differentiation genes (group III), as well as Wnt signaling pathway-related genes (group VI), which are in accordance with published data on bulk sorted cells [13, 14] . Interestingly, IL-7 expression was heterogeneous (group I), which might point to a differential function of BMSC subsets in bone marrow lymphopoiesis. Furthermore, variances in expression of chondrocyte differentiation marker SOX9 (Fig. 1D , group III) are likely to reflect differentiation potential differences. Low expression levels were observed for NES (group II), SOX10 (group V), as well as several group IV and VI genes. Finally, CD271 pos /CD140a low/neg cells clearly formed a distinct population as identified by principal component analysis compared with the non-CFU-F-containing CD271 neg cells (Fig. 1E ). In vitro, CD271 pos /CD140a low/neg cells formed typical spheres ( Fig. 2A) and CFU-F (not shown), the latter being the standard classical assay for clonogenic BM stromal cells. BMSCs were comparable in both assays (Fig. 2B) , and crossover replating experiments demonstrated that spheres and CFU-Fs had similar capacities to form secondary and tertiary CFU-Fs and spheres, respectively (Fig. 2C) . Furthermore, CD271 pos /CD140a low/neg -derived spheres exhibited a typical surface marker profile and in vitro differentiation pattern (Fig. 2D, E) , and increasing sphere numbers in vitro were observed up to the second passage (Fig. 2F) , which was comparable to standard CFU-F cultures (Fig. 2G) .
Taken together, these data indicate that CD271 pos / CD140a low/neg cells represent a highly enriched population of BMSCs with phenotypical stroma cell properties and in vitro mesensphere-forming capacity.
In vivo stem cell functions of CD271 pos / CD140a low/neg BMSCs Previous reports demonstrated in vitro stem/progenitor cell properties of human BMSCs [15, 16] . However, true stem cell properties cannot be assessed in vitro, but only in vivo by proving that a putative stem cell can generate cells that are functionally equivalent to the original.
Evidence that primary BMSCs are stem cells comes from seminal studies demonstrating that single CFU-F-derived clonal cells were capable of generating bone and hematopoietic stroma in vivo and that secondary CFU-F could be recovered from the transplants [1] . Furthermore, in vivo self-renewal of clonogenic cells was demonstrated for fetal human and adult murine BMSCs using the mesensphere assay [8, 17] . However, whether or not adult human BMSCs fulfill stringent stem cell criteria in a serial transplantation setting has not been thoroughly addressed thus far, although this is an important aspect when characterizing the nature and function of primary native BMSCs.
We therefore short-term expanded single-cell and bulksorted CD271 pos /CD140a low/neg BMSCs as spheres followed by subcutaneous implantation into immunodeficient mice (Fig. 3A) . After 8 weeks, implants were harvested, assayed for human spheres, and then retransplanted into secondary recipients. FACS-isolation of human transplanted cells was performed based on the expression of human CD90 and CD105 (Supplementary Fig. S2A ). CD90 and CD105 were chosen as sorting markers because of their relative stable expression in the transplanted cells in contrast to other markers. The sorting strategy and detection approach were validated by qPCR analysis of human and mouse housekeeping genes (Supplementary Fig. S2B ).
In vivo self-renewal of CD271 pos /CD140a low/neg BMSCs was demonstrated by increasing number of spheres after primary and secondary transplantation compared with pretransplantation values for both bulk-sorted (1.16 -0.06 and 2.34 -0.13-fold, respectively, n = 3) and single cell-derived spheres (1.54 -0.28 and 2.51 -0.72-fold, n = 3) (Fig. 3B and Supplementary Table S2 ). In contrast, implantation of adherently cultured CFU-Fs resulted in a more than 100-fold reduction of colony numbers after primary transplantation ( Supplementary Fig. S2C ), and therefore, secondary CFU-F transplantations were not performed.
In addition to in vivo sphere self-renewal, CD271 pos / CD140a low/neg BMSCs demonstrated serial in vivo differentiation capacity. Transplanted spheres generated human bone, adipocytes, and stromal tissues after primary and secondary implantation, with murine hematopoietic cells invading the implants (Fig. 3C, D, respectively) . There is cumulating evidence that differentiation potentials differ between stromal cells depending on their tissue of origin [18] [19] [20] . Our current work focused on BMSC and it therefore remains to be investigated whether or not stromal cell preparations from other sources have similar sphere formation and serial in vivo transplantation capacities.
Taken together, these results indicate that primary CD271 pos /CD140a low/neg BMSCs are capable of in vivo selfrenewal and differentiation. Cultures, which contained growth factors and prevented adherence to plastic, but not standard low/neg cells clearly demonstrated in vivo self-renewal indicated by increased numbers of total spheres after primary and secondary transplantations (data are given as mean -SD, n = 3, **P < 0.01, and ***P < 0.001). In contrast, numbers of CD271 pos / CD140a low/neg -derived CFU-F decreased after primary transplantation ( Supplementary Fig. S2C ). adherent cultures, enhanced stem cell properties and allowed to expand transplantable stromal stem cells, which is certainly an important finding for future studies aiming to design stroma stem cell replacement and repair strategies.
